Head to Head Analysis: Assure (NASDAQ:IONM) versus InfuSystem (NYSE:INFU)

Assure (NASDAQ:IONM) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.

Earnings & Valuation

This table compares Assure and InfuSystem”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assure	$149,000.00	1.01	-$26.08 million	N/A	N/A
InfuSystem	$139.89 million	1.41	$870,000.00	$0.23	41.87

InfuSystem has higher revenue and earnings than Assure.

Profitability

This table compares Assure and InfuSystem’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Assure	-25,178.32%	N/A	-249.78%
InfuSystem	1.12%	2.78%	1.41%

Analyst Ratings

This is a breakdown of recent ratings and price targets for Assure and InfuSystem, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Assure	0	0	0	0	0.00
InfuSystem	0	0	0	3	4.00

InfuSystem has a consensus target price of $12.50, indicating a potential upside of 29.80%. Given InfuSystem’s stronger consensus rating and higher probable upside, analysts clearly believe InfuSystem is more favorable than Assure.

Insider and Institutional Ownership

3.3% of Assure shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 3.8% of Assure shares are held by insiders. Comparatively, 11.4% of InfuSystem shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Assure has a beta of 185.75, indicating that its share price is 18,475% more volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500.

Summary

InfuSystem beats Assure on 11 of the 12 factors compared between the two stocks.

About Assure

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.

About InfuSystem

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.